4.7 Article

N-terminal alterations turn the gut hormone GLP-2 into an antagonist with gradual loss of GLP-2 receptor selectivity towards more GLP-1 receptor interaction

Journal

BRITISH JOURNAL OF PHARMACOLOGY
Volume 179, Issue 18, Pages 4473-4485

Publisher

WILEY
DOI: 10.1111/bph.15866

Keywords

antagonists; family B1 GPCR; GLP-1 receptor; GLP-2; GLP-2 receptor; GPCR; N-terminus

Funding

  1. Novo Nordisk Foundation [NNF18CC0034900]
  2. Faculty of Health and Medical Sciences, University of Copenhagen

Ask authors/readers for more resources

This study investigates the regulatory role of the GLP-2 system in the gut and bones by studying the effects of N-terminal truncations of human GLP-2 peptides on GLP-2 receptor activity and selectivity. The results show that the N-terminus of GLP-2 is crucial for GLP-2 receptor activity and selectivity. These findings provide a foundation for the development of tool compounds for further characterization of the GLP-2 system.
Background and Purpose To fully elucidate the regulatory role of the GLP-2 system in the gut and the bones, potent and selective GLP-2 receptor (GLP-2R) antagonists are needed. Searching for antagonist activity, we performed systematic N-terminal truncations of human GLP-2(1-33). Experimental Approach COS-7 cells were transfected with the human GLP-2R and assessed for cAMP accumulation or competition binding using I-125-GLP-2(1-33)[M10Y]. To examine selectivity, COS-7 cells expressing human GLP-1 or GIP receptors were assessed for cAMP accumulation. Key Results Affinity of the N-terminally truncated GLP-2 peptides for the GLP-2 receptor decreased with reduced N-terminal peptide length (K-i 6.5-871 nM), while increasing antagonism appeared with inhibitory potencies (IC50) values from 79 to 204 nM for truncation up to GLP-2(4-33) and then declined. In contrast, truncation-dependent increases in intrinsic activity were observed from an E-max of only 20% for GLP-(2-33) up to 46% for GLP-2(6-33) at 1 mu M, followed by a decline. GLP-2(9-33) had the highest intrinsic efficacy (E-max 65%) and no antagonistic properties. Moreover, with truncations up to GLP-2(8-33), a gradual loss in selectivity for the GLP-2 receptor appeared with increasing GLP-1 receptor (GLP-1R) inhibition (up to 73% at 1 mu M). Lipidation of the peptides improved antagonism (IC50 down to 7.9 nM) for both the GLP-2 and the GLP-1R. Conclusion and Implications The N-terminus of GLP-2 is crucial for GLP-2R activity and selectivity. Our observations form the basis for the development of tool compounds for further characterization of the GLP-2 system.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available